sThrombomodulin, Human, ELISA kit
Thrombomodulin (TM; CD141 or BDCA-3) is a 557 amino acid transmembrane glycoprotein predominantly expressed on the luminal surface of endothelial cells of most blood vessels, but also present in other gestational tissues like placenta and myometrium, polymorphonuclear neutrophils and monocytes. TM plays a central role in protection against excessive coagulation via protein C pathway, with subsequent inactivation of coagulation V and VIII. After processing and removal of the N-terminal site a 70-100KDa protein is obtained. TM consist of 5 domains: D1. CTLD, EGF-like D2, extracellular serine/threonine D3, transmembrane D4 and cytoplasmic D5. TM forms a complex with thrombin. This complex is needed in the conversion of protein C into its activated form (APC). APC leads to degradation of coagulation factor Va and VIIIa leading to continuation of its downstream pathway and consumption of thrombin. The binding to thrombin is 1:1 and the complex accelerated the activation of protein C significantly. When the coagulation cascade is activated, prothrombin is converted to thrombin by coagulation factors Va and VIIIa, ultimately leading to fibrin clot formation.
Although its primary function is to mediate endothelial thromboresistance, soluble variants comprising the extracellular domains are found in eg. serum and urine. Soluble TM (sTM) is considered as a marker of endothelial damage and retains its anticoagulant characteristics. Increased levels of sTM have been associated with inflammatory diseases related to damage endothelium like atherosclerosis and lung injury. STM has also been linked to inflammatory conditions. TM/thrombin complex can suppress cytokine production via APC. TM is also effective in the complement system by accelerating factor I inactivation of C3b. Mutations in TM can lead to overactive complement possibly leading to atypical hemolytic uremic syndrome.
Thrombomodulin assay HK383 is a 4.5h ELISA- assay making use of two monoclonal antibodies and uses a recombinant protein as standard. Parallelism between this standard and native human thrombomodulin has been shown, validating the use of this assay to reliably quantify human TM is samples.
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
- NEW Human C3d ELISAWe are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA